Breast Multidisciplinary Team Meetings

Slides:



Advertisements
Similar presentations
What is the most appropriate therapy for a 50 year old patient with T3N+ rectal cancer and isolated surgically resectable liver Metastases? – Systemic.
Advertisements

QT is a public domain oncological database designed for multidisciplinary Breast Units.
Cancer Support Services Locations: Providence Portland Medical Center Providence St. Vincent Medical Center Additional Resources: Ruth J. Spear Breast.
Breast Cancer in Pregnancy
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Gaurav Agarwal / Jul 2008 SGPGIMS, Lucknow, India Why is SGPGIMS Lucknow an ideal Hospital for state-of-the-art treatment of Breast Cancer.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Breast cancer and medical second opinion
Multi discipilinary team approach in Breast cancer (1) Fatih Agalar, MD, FACS, FEBS (hon) Prof of Surgery.
ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.
Cancer Survivorship: Transforming how we deliver cancer care Catherine Neck Macmillan Cancer Rehabilitation/ Recovery Package Project Lead.
16th Reach to Recovery International Breast Cancer Support Conference A pilot program of the implementation of Cancer Case Manager (breast) in Hong Kong.
March 2001Management of Thyroid CancerInformation Projects Team THE MANAGEMENT OF PATIENTS WITH THYROID CANCER Cathy Bennett Information Projects Manager.
File #1 Table of Contents Introduction Presenter’s Notes Oncology Rehabilitation: Web-based Learning for Physical Therapists Who Provide Rehabilitation.
Quality in Cancer Surgery Dr. Craig McFadyen VP Cancer Services, Grand River Hospital Regional VP (Waterloo-Wellington), Cancer Care Ontario Medical Director.
TEMPLATE DESIGN © ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC.
Introduction to Tumor Board
Linking Electronic Health Records Across Institutions to Understand Why Women Seek Care at Multiple Sites for Breast Cancer Caroline A. Thompson, PhD,
[Name of Presenter] [Details of patient e.g. initials, hospital number etc.] [Date of meeting]
MULTI-DISCIPLINARY CANCER MANAGEMENT John B. Hamner, MD, FACS Assistant Professor Surgical Oncology Tulane University.
Practical Oncology Experiences. What are the POEs? Practical sessions Promote understanding of technical aspects of Radiation Oncology Interaction with.
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
Who are Oncologists? The diagnosis, treatment & prevention of cancer is termed as Oncology and Oncologists are doctors who specialise in the treatment.
Overview: Breast Cancer- Surgical Treatment
A. Schema of NSABP B-27 trial comparing neoadjuvant AC to neoadjuvant AC followed by neoadjuvant docetaxel and to neoadjuvant AC followed by adjuvant docetaxel.
A Model for Breast Services in North Wales
HER2 and estrogen receptor status drive decisions regarding the use of neoadjuvant chemotherapy Neil Love, MD1, Kimberly L Blackwell, MD2, Eleftherios.
The POSITIVE study A large international research effort coordinated by International Breast Cancer Study Group (IBCSG) worldwide ALLIANCE for Clinical.
BREAST CANCER ONCOLOGY NAVIGATION SERVICE
Coordination (benign lesions)
NICE Guidance – Service delivery for patients with Sarcomas
Thoughtful Gifts For Someone With Cancer
Oncology for Family Medicine Residents:
FORM FOR REFERRING WOMEN WITH BREAST CANCER FOR GENETICS ASSESSMENT
Are we who we say we are? The difference made by Pastoral Care
Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis  Yi-Jhih.
CRUK working group MDT effectiveness proposal
A Multidisciplinary Team Approach Challenges and Best Practices in Cushing Disease.
New Views into the Prostate Cancer Genome
Perspectives on Triple-Negative Breast Cancer
Pathway for patients with suspected Breast Cancer
Update of breast cancer
Somerset Cancer Register
سرطان الثدي Breast Cancer
Apollo Gleneagles Hospitals,
Oncology Tru Miller White 2.
OSCE Mini exam clinical stations in surgery
Neuro Oncology Therapy Update
Hannah Marder Cancer Manager UH Bristol
Sarcoma Wound Complications
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Results from the first National Lung Cancer Organisational Audit.
Diagnosing Focal Epilepsy: A Clinical Case
Dr. V. J. Ekanem MBBCh, MSc, MHPM, FMCPath, FCPath (ECSA)
Clinical Decision Support In Action: Cancer Diagnosis
‘Improving Outcomes for people with skin tumours, including Melanoma’
Pathway for patients with suspected colorectal cancer
Clinical Decision Support In Action: Cancer Diagnosis
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Pathway for patients with suspected HPB Cancer Inter Provider Transfer
Cancer Survivorship: Transforming how we deliver cancer care
《Basic Clinical Oncology》 Lecture Fudan University Cancer Center
Laura, a breast cancer survivor, developed a serious cough
Pathway for patients with suspected Breast Cancer
MULTIDISCIPLINARY (MDT) APPROACH TO CLINICAL CARE MODEL FOR EFFECTIVE AND BEST EVIDENCE PATIENT CARE DR EZEKIEL ALAWALE MBBS, FWACS, FRCS(I), JCPTGP, GP.
Next-Generation Sequencing and ctDNA
Multidisciplinary Team Meeting Breast Care
Central Cancer Network regional workshop
MDTM Reforms from a Pathology Perspective
Presentation transcript:

Breast Multidisciplinary Team Meetings Oncology Survey

Your Role What is your current role? Clinical Oncologist Medical Oncologist Other

Diagnosis Should all patients undergoing needle biopsy or open surgical diagnostic biopsy be formally discussed at a MDTM ? Yes No Not Certain

Diagnosis Does an Oncologist need to be present for that discussion ? Yes No Not Certain

New Breast Cancer Diagnoses Should all newly diagnosed breast cancer cases be formally discussed at a MDTM before commencement of treatment ? Yes No Not Certain

New Breast Cancer Diagnoses Does an Oncologist need to be present at a MDTM to discuss ALL newly diagnosed breast cancer cases before the commencement of treatment ?  Yes No Not Certain

New Breast Cancer Diagnoses Does an Oncologist need to be present at a MDTM to discuss newly diagnosed breast cancer cases where neoadjuvant treatment is being considered as an option ?  Yes No Not Certain

Post Op Should all breast cancer cases undergoing surgery be formally discussed at a MDTM following surgery ? Yes No Not Certain

Post Op Does an Oncologist need to be present for that discussion ? Yes No Not Certain

Breast Cancer Recurrence Should all breast cancer cases of recurrent breast cancer be formally discussed at a MDTM ? Yes No Not Certain

Breast Cancer Recurrence Does an Oncologist need to be present for that discussion ? Yes No Not Certain

MDTM Transformation Would you be in favour of a reformed MDM system where only a small number of selected cases are formally discussed at a MDTM ? The majority of cases being placed on  pre-agreed, recognised treatment algorithms / pathways Yes No Not Certain

Have your say - MDTM Toolkit Please contribute your ideas to improve MDTM efficiency and if applicable give examples of changes made to your Breast MDTMs that may have already made them more efficient Please email your views / examples to: mdtmtoolkit@gmail.com